Manual site feasibility surveys are slow, repetitive, and resource-heavy—draining time from feasibility leads and delaying trial readiness. Building on last year’s introduction to survey automation, this session unveils the next phase of Pfizer’s GenAI-powered agent for site feasibility with new capabilities. Memory-aware Q&A, tailored site interactions, and explainable protocol-aligned recommendations accelerate how feasibility insights are generated and acted upon.
Key Takeaways:
• Agentic workflow: Three-phase system from survey building to chatbot-led interaction and result summarization
• Protocol-aware scoring: Automatically classifies sites based on protocol fit using LLM-generated summaries
• Redundancy reduction: Leverages memory to avoid asking sites the same questions across studies
Check out the incredible speaker line-up to see who will be joining João.
Download The Latest Agenda